IL134661A0 - Nootropics - Google Patents
NootropicsInfo
- Publication number
- IL134661A0 IL134661A0 IL13466198A IL13466198A IL134661A0 IL 134661 A0 IL134661 A0 IL 134661A0 IL 13466198 A IL13466198 A IL 13466198A IL 13466198 A IL13466198 A IL 13466198A IL 134661 A0 IL134661 A0 IL 134661A0
- Authority
- IL
- Israel
- Prior art keywords
- nootropics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9249131A JPH1180027A (ja) | 1997-09-12 | 1997-09-12 | 向知性薬 |
| PCT/JP1998/004136 WO1999013911A1 (fr) | 1997-09-12 | 1998-09-14 | Agent nootrope |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL134661A0 true IL134661A0 (en) | 2001-04-30 |
Family
ID=17188397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13466198A IL134661A0 (en) | 1997-09-12 | 1998-09-14 | Nootropics |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1022029A1 (xx) |
| JP (1) | JPH1180027A (xx) |
| KR (1) | KR20010030582A (xx) |
| CN (1) | CN1270528A (xx) |
| AU (1) | AU9003598A (xx) |
| BR (1) | BR9815370A (xx) |
| CA (1) | CA2301782A1 (xx) |
| ID (1) | ID24282A (xx) |
| IL (1) | IL134661A0 (xx) |
| NO (1) | NO20001196L (xx) |
| WO (1) | WO1999013911A1 (xx) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW544311B (en) * | 1998-08-06 | 2003-08-01 | Daiichi Seiyaku Co | Therapeutic or preventive agent for intractable epilepsies |
| KR20020015321A (ko) * | 1999-05-31 | 2002-02-27 | 스즈키 다다시 | 신경 세포사 억제제 |
| GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
| US6423739B1 (en) * | 2000-02-23 | 2002-07-23 | Daiichi Pharmaceutical Co., Ltd. | Method for aiding cerebral recovery following neurodegeneration |
| US6348489B1 (en) * | 2000-04-11 | 2002-02-19 | Daiichi Pharmaceutical Co., Ltd. | Method of treating traumatic brain injury and other neuronal disorders |
| GB0021885D0 (en) * | 2000-09-06 | 2000-10-18 | Fujisawa Pharmaceutical Co | New use |
| EP1420782B1 (en) * | 2001-08-22 | 2008-08-13 | Hamilton Pharmaceuticals, Inc. | Use of nefiracetam for treating post-stroke neurodegeneration |
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| DK2355822T3 (da) | 2008-11-19 | 2013-01-28 | Envivo Pharmaceuticals Inc | behandling af kognitive forstyrrelser med (R)-7-chlor-N-(quinuclidin-3-yl)benzoe[b]thiophen-2-carboxamid og farmaceutisk acceptable salte deraf |
| ES2746850T3 (es) | 2010-05-17 | 2020-03-09 | Forum Pharmaceuticals Inc | Formulaciones farmacéuticas que comprenden formas cristalinas de clorhidrato de (R)-7-cloro-N-(quinuclidin-3-il)benzo(b)tiofeno-2-carboxamida monohidratado |
| AU2013259871A1 (en) | 2012-05-08 | 2014-11-20 | Forum Pharmaceuticals Inc. | Methods of maintaining, treating or improving cognitive function |
| JP6066312B2 (ja) * | 2013-03-29 | 2017-01-25 | 国立研究開発法人理化学研究所 | 細胞膜片を備えた発電素子および発電デバイス |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA923134B (en) * | 1991-05-02 | 1993-01-27 | Daiichi Seiyaku Co | Agent for improving dementia |
| JP3388778B2 (ja) * | 1991-05-02 | 2003-03-24 | 第一製薬株式会社 | 脳血管性痴呆改善剤 |
| JPH06279311A (ja) * | 1993-03-26 | 1994-10-04 | Sagami Chem Res Center | プロテインキナーゼｃアイソザイムの活性化剤 |
-
1997
- 1997-09-12 JP JP9249131A patent/JPH1180027A/ja active Pending
-
1998
- 1998-09-14 IL IL13466198A patent/IL134661A0/xx unknown
- 1998-09-14 EP EP98941864A patent/EP1022029A1/en not_active Withdrawn
- 1998-09-14 CN CN98809035A patent/CN1270528A/zh active Pending
- 1998-09-14 WO PCT/JP1998/004136 patent/WO1999013911A1/ja not_active Application Discontinuation
- 1998-09-14 CA CA002301782A patent/CA2301782A1/en not_active Abandoned
- 1998-09-14 KR KR1020007002597A patent/KR20010030582A/ko not_active Application Discontinuation
- 1998-09-14 AU AU90035/98A patent/AU9003598A/en not_active Abandoned
- 1998-09-14 BR BR9815370-6A patent/BR9815370A/pt not_active IP Right Cessation
- 1998-09-14 ID IDW20000459A patent/ID24282A/id unknown
-
2000
- 2000-03-08 NO NO20001196A patent/NO20001196L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU9003598A (en) | 1999-04-05 |
| WO1999013911A1 (fr) | 1999-03-25 |
| ID24282A (id) | 2000-07-13 |
| BR9815370A (pt) | 2000-10-24 |
| CA2301782A1 (en) | 1999-03-25 |
| CN1270528A (zh) | 2000-10-18 |
| NO20001196D0 (no) | 2000-03-08 |
| NO20001196L (no) | 2000-05-10 |
| KR20010030582A (ko) | 2001-04-16 |
| JPH1180027A (ja) | 1999-03-23 |
| EP1022029A1 (en) | 2000-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL335999A1 (en) | Substituted 3-cyanoquinolines | |
| AP2000001795A0 (en) | Substituted 4-aminothiazol-2-yol | |
| GB9714102D0 (en) | Compounds | |
| GB9710569D0 (en) | Compounds | |
| GB9708694D0 (en) | Compounds | |
| GB9708805D0 (en) | Compounds | |
| IL134661A0 (en) | Nootropics | |
| GB9709303D0 (en) | Compounds | |
| GB9711492D0 (en) | Compounds | |
| PL334546A1 (en) | Substituted 4-benzoylpyrazoles | |
| GB9704522D0 (en) | Compounds | |
| GB9712849D0 (en) | Compounds | |
| IL133261A0 (en) | Substituted naphthropyrans | |
| ZA985761B (en) | Substituted aryluracils | |
| PL341280A1 (en) | Substituted beta-alanines | |
| GB9704652D0 (en) | Compounds | |
| GB9702646D0 (en) | Compounds | |
| GB9702240D0 (en) | Compounds | |
| GB9700393D0 (en) | Compounds | |
| GB9700255D0 (en) | Compounds | |
| GB9704580D0 (en) | Compounds | |
| GB9704581D0 (en) | Compounds | |
| GB9704551D0 (en) | Compounds | |
| GB9702608D0 (en) | Compounds | |
| GB9705188D0 (en) | Compounds |